Kolon Life Sciences has attained approval in South Korea for a first-in-class cell-mediated gene therapy designed to treat osteoarthritis through regeneration of cartilage. “Kolon has said injection of Invossa has been shown in Phase III trials in Korea to ease the symptoms of about 84% of patients – while 88% of U.S. patients treated with Read more about Can Gene Therapy Stop the Progression of Osteoarthritis?[…]